Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.49% | 132.33 | 0.0% | $2558.09m | |
| BNGO | BioNano Genomics, Inc. | 11.25% | 9.20 | 0.0% | $1880.56m | |
| GILD | Gilead Sciences, Inc. | 0.64% | 67.41 | 1.0% | $666.95m | |
| AMGN | Amgen, Inc. | 1.14% | 254.90 | 1.3% | $566.31m | |
| CRSP | CRISPR Therapeutics AG | 1.52% | 187.91 | 0.6% | $493.36m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.29% | 159.90 | 2.0% | $482.99m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.45% | 543.24 | 2.7% | $480.77m | |
| NVAX | Novavax, Inc. | 1.41% | 124.12 | 92.9% | $434.84m | |
| ILMN | Illumina, Inc. | 0.66% | 407.56 | 3.5% | $396.91m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.69% | 240.29 | 1.9% | $362.91m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.36% | 97.27 | 13.8% | $357.88m | |
| BIIB | Biogen, Inc. | 0.02% | 270.19 | 1.7% | $326.74m | |
| BNTX | BioNTech SE | 1.63% | 107.15 | 0.0% | $304.43m | |
| EXAS | EXACT Sciences Corp. | 0.57% | 148.91 | 19.6% | $241.24m | |
| PACB | Pacific Biosciences of California, Inc. | 2.73% | 37.30 | 7.4% | $237.10m |
Company Profile
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products include immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.